Home / Health / Breakthrough Blood Test Could Spot Deadly Cancer Sooner
Breakthrough Blood Test Could Spot Deadly Cancer Sooner
2 Feb
Summary
- New blood test combines four markers for 92% accuracy.
- Test differentiates cancer from non-cancerous conditions.
- Could screen high-risk individuals before symptoms appear.
A groundbreaking blood test is offering new hope in the fight against pancreatic cancer, a disease notoriously difficult to diagnose and treat.
Developed by scientists at the University of Pennsylvania and the Mayo Clinic, this innovative test combines four blood markers to detect pancreatic ductal adenocarcinoma, the most common and aggressive form of the cancer. The test demonstrated an impressive 92% accuracy rate in identifying the disease, with only a 5% false alarm rate for healthy individuals.
Crucially, the new test can differentiate between cancerous and non-cancerous conditions, a significant improvement over previous methods. Researchers are optimistic that this test could be used to screen individuals at higher risk, such as those with a family history or existing pancreatic conditions, potentially catching the cancer in its earliest, most treatable stages.
